BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bratt T. Lipocalins and cancer. Biochim Biophys Acta. 2000;1482:318-326. [PMID: 11058772 DOI: 10.1016/s0167-4838(00)00154-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Nicholas BL, Skipp P, Barton S, Singh D, Bagmane D, Mould R, Angco G, Ward J, Guha-Niyogi B, Wilson S, Howarth P, Davies DE, Rennard S, O'Connor CD, Djukanovic R. Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:1049-60. [PMID: 20110559 DOI: 10.1164/rccm.200906-0857OC] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
2 McLean MH, Thomson AJ, Murray GI, Fyfe N, Hold GL, El-Omar EM. Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential? Br J Cancer. 2013;108:2537-2541. [PMID: 23736029 DOI: 10.1038/bjc.2013.264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
3 Laurell H, Bouisson M, Berthelémy P, Rochaix P, Déjean S, Besse P, Susini C, Pradayrol L, Vaysse N, Buscail L. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006; 12(21): 3344-3351 [PMID: 16733850 DOI: 10.3748/wjg.v12.i21.3344] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
4 Wang X, Li A, Guo Y, Wang Y, Zhao X, Xiang L, Han Z, Li Y, Xu W, Zhuang K, Yan Q, Zhong J, Xiong J, Liu S. iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors. Sci Rep 2016;6:28600. [PMID: 27339395 DOI: 10.1038/srep28600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Barresi V, Lucianò R, Vitarelli E, Labate A, Tuccari G, Barresi G. Neutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: A stage-specific prognostic factor? Oncol Lett 2010;1:1089-96. [PMID: 22870118 DOI: 10.3892/ol.2010.191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yeh YH, Chang JL, Hsiao PC, Tsao SM, Lin CH, Kao SJ, Chou MC, Yang SF, Chien MH. Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia. J Clin Lab Anal 2013;27:253-60. [PMID: 23852780 DOI: 10.1002/jcla.21588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Savaris RF, Hamilton AE, Lessey BA, Giudice LC. Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy. Reprod Sci 2008;15:797-816. [PMID: 18591649 DOI: 10.1177/1933719108317585] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ding G, Wang J, Feng C, Jiang H, Xu J, Ding Q. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity. Oncotarget 2016;7:64309-17. [PMID: 27602760 DOI: 10.18632/oncotarget.11790] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
9 Putney LK, Barber DL. Expression profile of genes regulated by activity of the Na-H exchanger NHE1. BMC Genomics. 2004;5:46. [PMID: 15257760 DOI: 10.1186/1471-2164-5-46] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 3.5] [Reference Citation Analysis]
10 Sun Y, Yokoi K, Li H, Gao J, Hu L, Liu B, Chen K, Hamilton SR, Fan D, Sun B, Zhang W. NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res 2011;17:4331-40. [PMID: 21622717 DOI: 10.1158/1078-0432.CCR-11-0226] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
11 Gong Z, Hong F, Wang H, Zhang X, Chen J. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma. BMC Med Genet 2020;21:56. [PMID: 32188434 DOI: 10.1186/s12881-020-0992-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Tong Z, Wu X, Kehrer JP. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem J 2003;372:203-10. [PMID: 12614196 DOI: 10.1042/BJ20021696] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
13 Wang J, Ma R, Sharma A, He M, Xue J, Wu J, Dun B, Li G, Wang X, Ji M, She JX, Tang J. Inflammatory serum proteins are severely altered in metastatic gastric adenocarcinoma patients from the Chinese population. PLoS One 2015;10:e0123985. [PMID: 25884401 DOI: 10.1371/journal.pone.0123985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
14 Alcayaga-Miranda F, Cuenca J, Khoury M. Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. Front Immunol 2017;8:339. [PMID: 28424688 DOI: 10.3389/fimmu.2017.00339] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 23.5] [Reference Citation Analysis]
15 Loch CM, Ramirez AB, Liu Y, Sather CL, Delrow JJ, Scholler N, Garvik BM, Urban ND, McIntosh MW, Lampe PD. Use of high density antibody arrays to validate and discover cancer serum biomarkers. Mol Oncol 2007;1:313-20. [PMID: 19383305 DOI: 10.1016/j.molonc.2007.08.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
16 Roll JD, Rivenbark AG, Jones WD, Coleman WB. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 2008;7:15. [PMID: 18221536 DOI: 10.1186/1476-4598-7-15] [Cited by in Crossref: 149] [Cited by in F6Publishing: 137] [Article Influence: 11.5] [Reference Citation Analysis]
17 Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP. Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 2005;391:441-8. [PMID: 16060857 DOI: 10.1042/BJ20051020] [Cited by in Crossref: 127] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
18 Zhou Y, Rui L. Lipocalin 13 regulation of glucose and lipid metabolism in obesity. Vitam Horm 2013;91:369-83. [PMID: 23374724 DOI: 10.1016/B978-0-12-407766-9.00015-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
19 Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A 2009;106:3913-8. [PMID: 19237579 DOI: 10.1073/pnas.0810617106] [Cited by in Crossref: 215] [Cited by in F6Publishing: 218] [Article Influence: 17.9] [Reference Citation Analysis]
20 Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer. 2008;98:1540-1547. [PMID: 18392050 DOI: 10.1038/sj.bjc.6604329] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 8.5] [Reference Citation Analysis]
21 Mannelqvist M, Stefansson IM, Wik E, Kusonmano K, Raeder MB, Øyan AM, Kalland KH, Moses MA, Salvesen HB, Akslen LA. Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer 2012;12:169. [PMID: 22559235 DOI: 10.1186/1471-2407-12-169] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
22 Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2021;22:2865. [PMID: 33799862 DOI: 10.3390/ijms22062865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lee JH, Kye KC, Seo EY, Lee K, Lee SK, Lim JS, Seo YJ, Kim CD, Park JK. Expression of neutrophil gelatinase-associated lipocalin in calcium-induced keratinocyte differentiation. J Korean Med Sci 2008;23:302-6. [PMID: 18437016 DOI: 10.3346/jkms.2008.23.2.302] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
24 Veloso JF, Brandão Guedes PE, Lacerda LC, Santana JO, Mora-Ocampo IY, Pirovani CP, Oriá AP, Munhoz AD, Alberto Carlos RS. Tear Film Proteome of Healthy Domestic Cats. Vet Med Int 2021;2021:8708023. [PMID: 34326982 DOI: 10.1155/2021/8708023] [Reference Citation Analysis]
25 Du ZP, Wu BL, Wu X, Lin XH, Qiu XY, Zhan XF, Wang SH, Shen JH, Zheng CP, Wu ZY, Xu LY, Wang D, Li EM. A systematic analysis of human lipocalin family and its expression in esophageal carcinoma. Sci Rep 2015;5:12010. [PMID: 26131602 DOI: 10.1038/srep12010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
26 Verma M, Dahiya K, Soni A, Dhankhar R, Ghalaut VS, Bansal A, Kaushal V. Levels of neutrophil gelatinase-assosciated lipocalin in patients with head and neck squamous cell carcinoma in Indian population from Haryana state. World J Clin Oncol 2017; 8(3): 261-265 [PMID: 28638796 DOI: 10.5306/wjco.v8.i3.261] [Reference Citation Analysis]
27 Sborchia M, Keun HC, Phillips DH, Arlt VM. The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo. Int J Mol Sci 2019;20:E6155. [PMID: 31817608 DOI: 10.3390/ijms20246155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lee YC, Tzeng WF, Chiou TJ, Chu ST. MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity. PLoS One. 2012;7:e52979. [PMID: 23300839 DOI: 10.1371/journal.pone.0052979] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
29 Wenners AS, Mehta K, Loibl S, Park H, Mueller B, Arnold N, Hamann S, Weimer J, Ataseven B, Darb-Esfahani S, Schem C, Mundhenke C, Khandan F, Thomssen C, Jonat W, Holzhausen HJ, von Minckwitz G, Denkert C, Bauer M. Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer. PLoS One 2012;7:e45826. [PMID: 23056218 DOI: 10.1371/journal.pone.0045826] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
30 Hu C, Yang K, Li M, Huang W, Zhang F, Wang H. Lipocalin 2: a potential therapeutic target for breast cancer metastasis. Onco Targets Ther 2018;11:8099-106. [PMID: 30519052 DOI: 10.2147/OTT.S181223] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
31 Wei CT, Tsai IT, Wu CC, Hung WC, Hsuan CF, Yu TH, Hsu CC, Houng JY, Chung FM, Lee YJ, Lu YC. Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer. Int J Med Sci 2021;18:2689-96. [PMID: 34104101 DOI: 10.7150/ijms.58789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]